📖
Taselisib, a PI3K Inhibitor, Alleviates Neuropathic Pain through HIF-1α-Mediated Angiogenesis in a Rat Model of Chronic Constriction Injury.
You HP, Zhang LH, Li CY, He HF, Chen ZY, Wang HG, Liu WF, Xu CJ

Taselisib, a PI3K Inhibitor, Alleviates Neuropathic Pain through HIF-1α-Mediated Angiogenesis in a Rat Model of Chronic Constriction Injury.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Neuroimmunomodulation.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Taselisib, a PI3K Inhibitor, Alleviates Neuropathic Pain through HIF-1α-Mediated Angiogenesis in a Rat Model of Chronic Constriction Injury.
Author / Organization You HP, Zhang LH, Li CY, He HF, Chen ZY, Wang HG, Liu WF, Xu CJ
Subject & Discipline Neuroimmunomodulation
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-68282
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »